Literature DB >> 8495592

Synergy assessed by checkerboard. A critical analysis.

M H Hsieh1, C M Yu, V L Yu, J W Chow.   

Abstract

The checkerboard dilution test is widely used for evaluation of in vitro synergy for multiple drugs, although problems in performance, standardization, and interpretation have been noted. A major problem inherent in this commonly used method is the use of twofold dilutions for the antibiotic concentrations. We evaluated an alternative method proposed by Horrevorts and colleagues that preserved the twofold dilution scheme. Giant checkerboards were constructed from a series of component checkerboards using rifampin and minocycline against Staphylococcus aureus. We found that this method improved the stability of the fractional inhibitory concentration (FIC) indices, but required substantially more labor and generated other problems. FIC interpretation and calculation remained compromised by the twofold dilution scheme. We have analyzed the theoretical basis of the checkerboard and its FIC calculation and conclude that the twofold dilution with its exponential increase in dilutions makes this method of synergy evaluation inherently unstable. The principle of examining growth at multiple dilutions of combined antibiotics is valid for assessment of synergy, but newer methods need to be devised.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495592     DOI: 10.1016/0732-8893(93)90087-n

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  78 in total

1.  β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.

Authors:  Elizabeth Story-Roller; Christos Galanis; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

2.  A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.

Authors:  Jing He; Charles G Starr; William C Wimley
Journal:  Biochim Biophys Acta       Date:  2014-09-28

3.  Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro.

Authors:  Elizabeth Story-Roller; Emily C Maggioncalda; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

4.  Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 revitalizes its use in combinatorial drug therapy.

Authors:  Sudip Regmi; Yun Hee Choi; Yoon Seok Choi; Mi Ri Kim; Jin Cheol Yoo
Journal:  Folia Microbiol (Praha)       Date:  2016-10-27       Impact factor: 2.099

5.  High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method.

Authors:  Morgan A Wambaugh; Jessica C S Brown
Journal:  J Vis Exp       Date:  2018-05-21       Impact factor: 1.355

6.  Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.

Authors:  Juan Carlos Vázquez-Ucha; María Maneiro; Marta Martínez-Guitián; John Buynak; Christopher R Bethel; Robert A Bonomo; Germán Bou; Margarita Poza; Concepción González-Bello; Alejandro Beceiro
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

7.  Synergy of streptogramin antibiotics occurs independently of their effects on translation.

Authors:  Jonas Noeske; Jian Huang; Nelson B Olivier; Robert A Giacobbe; Mark Zambrowski; Jamie H D Cate
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

8.  Sulfide Protects Staphylococcus aureus from Aminoglycoside Antibiotics but Cannot Be Regarded as a General Defense Mechanism against Antibiotics.

Authors:  Julia Weikum; Niklas Ritzmann; Nils Jelden; Anna Klöckner; Sebastian Herkersdorf; Michaele Josten; Hans-Georg Sahl; Fabian Grein
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

9.  Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?

Authors:  Maria S Zharkova; Dmitriy S Orlov; Olga Yu Golubeva; Oleg B Chakchir; Igor E Eliseev; Tatyana M Grinchuk; Olga V Shamova
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

10.  Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.

Authors:  Amit Kaushik; Nayani Makkar; Pooja Pandey; Nicole Parrish; Urvashi Singh; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.